• In age-, race-, and sex-matched groups, the relative abilities of medrysone, fluorometholone, and dexamethasone phosphate to elevate intraocular pressure were compared in a masked manner. Compliance was controlled by drops being given by nursing personnel. The 18 male hospitalized volunteers received commercial preparations of one of the corticosteroids to each eye four times a day for six weeks. The relative ability of medrysone, fluorometholone, and dexamethasone phosphate to raise IOP was 1, 4, and 7.6, respectively.
Mindel JS, Tavitian HO, Smith H, Walker EC. Comparative Ocular Pressure Elevation by Medrysone, Fluorometholone, and Dexamethasone Phosphate. Arch Ophthalmol. 1980;98(9):1577–1578. doi:10.1001/archopht.1980.01020040429006
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: